Concepedia

Venkatasubramanian Ulaganathan

VU

Statistics

Publications

16

Citations

654

H-Index

14

Active since

2001

Affiliations

Cancer Research UK Scotland Institute(Current)

SASTRA University

University of Dundee

Carnegie Mellon University

University of Graz

Venkatasubramanian Ulaganathan is an author at Cancer Research UK Scotland Institute specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2001–2019

16

Publications

16

Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol

Hung Yi Kristal Kaan, Venkatasubramanian Ulaganathan, Oliver Rath et al. · Journal of Medicinal Chemistry · 2010 · 151 citations · Full text

, , +15

An allosteric transition trapped in an intermediate state of a new kinesin–inhibitor complex

Hung Yi Kristal Kaan, Venkatasubramanian Ulaganathan, David D. Hackney et al. · Biochemical Journal · 2009 · 69 citations · Full text

, , +17

Structural Insights into a Unique Inhibitor Binding Pocket in Kinesin Spindle Protein

Venkatasubramanian Ulaganathan, Sandeep K. Talapatra, Oliver Rath et al. · Journal of the American Chemical Society · 2013 · 58 citations

, , +15

Structure–Activity Relationships and Molecular Docking of Novel Dihydropyrimidine‐Based Mitotic Eg5 Inhibitors

Hana Prokopcová, Doris Dallinger, Georg Uray et al. · ChemMedChem · 2010 · 45 citations

, , +17

Structure−Activity Relationship and Multidrug Resistance Study of New <i>S</i>-trityl-<scp>l</scp>-Cysteine Derivatives As Inhibitors of Eg5

Hung Yi Kristal Kaan, D. Menger, Venkatasubramanian Ulaganathan et al. · Journal of Medicinal Chemistry · 2011 · 43 citations · Full text

, , +17

1–5 of 16